Glycopyrrolate Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Glycopyrrolate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jul 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
65219-801-01
Dosage Form
Injection
Presentation
Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)
Initial Posting
Jul 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.